Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Maria Di Ioia"'
Autor:
Maria di Ioia, Vincenzo Di Stefano, Deborah Farina, Valeria Di Tommaso, Daniela Travaglini, Erika Pietrolongo, Stefano L. Sensi, Marco Onofrj, Giovanna De Luca
Publikováno v:
Data in Brief, Vol 29, Iss , Pp - (2020)
Alemtuzumab is approved for highly active MS and, in Europe, can be employed after other disease-modifying treatments (DMTs) as an escalation approach or first therapeutic option. The occurrence of secondary autoimmune adverse events and infections d
Externí odkaz:
https://doaj.org/article/f7becc84382b46c9828f726a569c2cac
Autor:
Silvia Valentinuzzi, Giovanna De Luca, Antonio Maria Chiarelli, Valentina Tomassini, Damiana Pieragostino, Richard G. Wise, Eleonora Grasso, Piero Del Boccio, Alessandro Villani, Anna Digiovanni, Marianna Gabriella Rispoli, Luca Federici, Maria di Ioia, Valeria Pozzilli, Marco Onofrj
Publikováno v:
International Journal of Molecular Sciences
International Journal of Molecular Sciences, Vol 22, Iss 11112, p 11112 (2021)
International Journal of Molecular Sciences, Vol 22, Iss 11112, p 11112 (2021)
Metabolomics-based technologies map in vivo biochemical changes that may be used as early indicators of pathological abnormalities prior to the development of clinical symptoms in neurological conditions. Metabolomics may also reveal biochemical path
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7feeccdcb6869c69023762a77d0a72eb
http://europepmc.org/articles/PMC8541167
http://europepmc.org/articles/PMC8541167
Autor:
Marco Onofrj, Stefano L. Sensi, Giovanna De Luca, Vincenzo Di Stefano, Maria di Ioia, Valeria Di Tommaso, D. Farina, Erika Pietrolongo, D. Travaglini
Publikováno v:
Data in Brief
Data in Brief, Vol 29, Iss, Pp-(2020)
Data in Brief, Vol 29, Iss, Pp-(2020)
Alemtuzumab is approved for highly active MS and, in Europe, can be employed after other disease-modifying treatments (DMTs) as an escalation approach or first therapeutic option. The occurrence of secondary autoimmune adverse events and infections d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cfc7d114586458629101430a8ee56f22
http://hdl.handle.net/10447/520469
http://hdl.handle.net/10447/520469
Autor:
Piero Del Boccio, Marco Onofrj, Eva Ercolino, Paolo Sacchetta, Paola Lanuti, Marco Marchisio, Ilaria Cicalini, Damiana Pieragostino, Maria di Ioia, Romina Zappacosta, Mirco Zucchelli, Sebastiano Miscia
Publikováno v:
Scientific Reports, Vol 8, Iss 1, Pp 1-12 (2018)
Scientific Reports
Scientific Reports
Multiple Sclerosis (MuS) is a complex multifactorial neuropathology, resulting in heterogeneous clinical presentation. A very active MuS research field concerns the discovery of biomarkers helpful to make an early and definite diagnosis. The sphingom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::112f00c08becb907fb5556cfa7dcaab4
http://link.springer.com/article/10.1038/s41598-018-21497-5
http://link.springer.com/article/10.1038/s41598-018-21497-5
Autor:
Alessandro Villani, Paola Ajdinaj, Maria D'Apolito, Silvia Valentinuzzi, Piero Del Boccio, Eleonora Grasso, Anna Digiovanni, Valeria Pozzilli, Marianna Gabriella Rispoli, Damiana Pieragostino, Maria di Ioia, Giovanna De Luca, Valentina Tomassini
Publikováno v:
Journal of the Neurological Sciences. 429:118155
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bf6b9f10c3b2bd44a90a3d2142275206
https://doi.org/10.1016/j.jns.2021.118155
https://doi.org/10.1016/j.jns.2021.118155
Autor:
Maria di Ioia, D. Travaglini, Marco Onofrj, Giovanna De Luca, Valeria Di Tommaso, D. Farina, Erika Pietrolongo
Publikováno v:
Multiple Sclerosis Journal. 24:813-815
Background: Alemtuzumab, approved for multiple sclerosis (MS), can cause secondary autoimmune adverse events including thyroid disorders, immune thrombocytopenia (ITP), and glomerular nephropathies. Non-ITP autoimmune cytopenias are rarely reported.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4982c67823fc5c02830c6294907839ac
https://doi.org/10.1177/1352458517743093
https://doi.org/10.1177/1352458517743093
Autor:
Claudia Rossi, Luca Federici, Marco Onofrj, Giovanna De Luca, Ilaria Cicalini, Luca Agnifili, Leonardo Mastropasqua, Damiana Pieragostino, Maria di Ioia, Piero Del Boccio
Publikováno v:
International Journal of Molecular Sciences
Volume 20
Issue 6
International Journal of Molecular Sciences, Vol 20, Iss 6, p 1265 (2019)
Volume 20
Issue 6
International Journal of Molecular Sciences, Vol 20, Iss 6, p 1265 (2019)
Metabolomics based on mass spectrometry represents an innovative approach to characterize multifactorial diseases, such as multiple sclerosis (MuS). To date, the most important biomarker source for MuS diagnosis is the cerebrospinal fluid. However, a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eea68ef47a4e67c3b2622d97f68b46d7
http://europepmc.org/articles/PMC6471885
http://europepmc.org/articles/PMC6471885
Autor:
Damiana Pieragostino, Claudia Rossi, Piero Del Boccio, Maria di Ioia, Ilaria Cicalini, Paolo Sacchetta
Publikováno v:
PROTEOMICS - Clinical Applications. 10:470-484
Personalized medicine is the science of individualized prevention and therapy. In the last decade, advances in high-throughput approaches allowed the development of proteomic and metabolomic studies in evaluating the association of genetic and phenot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71009c5938a5a42662d14f81cb64204b
https://doi.org/10.1002/prca.201500083
https://doi.org/10.1002/prca.201500083
Autor:
Marco Onofrj, Luca Federici, Ilaria Cicalini, Mirco Zucchelli, Damiana Pieragostino, Claudia Rossi, Piero Del Boccio, Maria di Ioia
Publikováno v:
International Journal of Molecular Sciences
Volume 19
Issue 11
International Journal of Molecular Sciences, Vol 19, Iss 11, p 3589 (2018)
Volume 19
Issue 11
International Journal of Molecular Sciences, Vol 19, Iss 11, p 3589 (2018)
Multiple sclerosis (MuS) is an autoimmune disease of the central nervous system characterized by neuroinflammation, neurodegeneration, and degradation of the myelin sheath. Epidemiological studies have shown that the female gender is more susceptible
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad3273c1d4fed788b3693ca219cc1e68
Autor:
Luca Prosperini, Pietro Annovazzi, Laura Boffa, Maria Chiara Buscarinu, Antonio Gallo, Manuela Matta, Lucia Moiola, Luigina Musu, Paola Perini, Carlo Avolio, Valeria Barcella, Assunta Bianco, Deborah Farina, Elisabetta Ferraro, Simona Pontecorvo, Franco Granella, Luigi M E Grimaldi, Alice Laroni, Giacomo Lus, Francesco Patti, Eugenio Pucci, Matteo Pasca, Paola Sarchielli, Angelo Ghezzi, Mauro Zaffaroni, Damiano Baroncini, Fabio Buttari, Diego Centonze, Arianna Fornasiero, Marco Salvetti, Renato Docimo, Elisabetta Signoriello, Gioacchino Tedeschi, Antonio Bertolotto, Marco Capobianco, Giancarlo Comi, Eleonora Cocco, Paolo Gallo, Marco Puthenparampil, Roberta Grasso, Valeria Di Francescantonio, Maria Rosaria Rottoli, Massimiliano Mirabella, Alessandra Lugaresi, Giovanna De Luca, Maria Di Ioia, Valeria Di Tommaso, Luca Mancinelli, Giancarlo Di Battista, Ada Francia, Serena Ruggieri, Carlo Pozzilli, Erica Curti, Elena Tsantes, Barbara Palmeri, Caterina Lapicci, Giovanni Luigi Mancardi, Antonio Uccelli, Clara Chisari, Emanuele D'Amico, Elisabetta Cartechini, Anna Maria Repice, Eliana Magnani, Luca Massaccesi, Paolo Calabresi, Massimiliano Di Filippo, Maria Di Gregorio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3977::08d79b041d5e8685ca134d760a3baf02
http://hdl.handle.net/11591/455514
http://hdl.handle.net/11591/455514